Alignment Healthcare Q4 2023 GAAP EPS $(0.25) Misses $(0.22) Estimate, Sales $465.39M Beat $444.60M Estimate
Portfolio Pulse from Benzinga Newsdesk
Alignment Healthcare (NASDAQ:ALHC) reported Q4 2023 earnings with a GAAP EPS of $(0.25), missing the $(0.22) estimate, but surpassed sales expectations with $465.39M against a $444.60M estimate, marking a 28.63% increase from the previous year.
February 27, 2024 | 9:44 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Alignment Healthcare reported a Q4 2023 GAAP EPS of $(0.25), missing estimates, but exceeded sales forecasts with $465.39M, a 28.63% YOY increase.
While ALHC missed EPS estimates, indicating potential concerns about profitability, the significant beat on sales forecasts and a substantial year-over-year growth suggest strong revenue generation capabilities. This mixed result could lead to neutral short-term stock price movement as investors weigh the implications of missed EPS against strong sales performance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100